ViraxClear to distribute up to 3 million COVID-19 Rapid Antibody Test Kits to Chile

Global Care Capital Inc. is pleased to announce that its portfolio company, ViraxClear, through its joint venture with Shanghai Biotechnology Devices Ltd. has received approval from El Instituto de Salud Pública de Chile for the distribution of COVID-19 Rapid Antibody Test Kits. ViraxClear has signed a non-binding LOI with Biosonda Biotecnologia for the distribution of up to 3 million test kits for the Chilean market, a contract valued at up to $17.25 million in gross revenue.

Source: Globe Newswire